ClinicalTrials.govpublic full text
Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA
hepatitis b, chronic, chronic hepatitis b, lamivudine, entecavir, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 905840
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.